Clin Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Capell, P.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Capell, P.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Clinical Diabetes 22:101-102, 2004
© American Diabetes Association ®, Inc., 2004


Case Study

Case Study: Hemachromatosis in Type 2 Diabetes

Peter Capell, MD

The first 20% of the full text of this article appears below.


    Presentation
 
G.O. is a 50-year-old white man referred for help in managing his diabetes. Two years before his visit, diabetes was diagnosed during a routine exam. He was started on oral hypoglycemic agents. He initially responded to this treatment, but over the ensuing 2 years, his medication doses were slowly raised until he was on 15 mg glyburide and 2,000 mg metformin. At the time of referral, his fasting blood glucose levels were in the range of 150 mg/dl and his hemoglobin A1c (A1C) was 8%. He requested a consultation when he was advised to start on insulin therapy.

His medical history was significant for heavy alcohol intake and hepatitis B with full recovery. Family history was negative for diabetes and hemochromatosis. His review of systems was positive for joint discomfort in his hands and erectile dysfunction.

Physical exam revealed normal vital signs and no retinopathy or other signs of diabetic complications. His hand joints showed mild swelling and tenderness over the proximal interphalangeal joints, and his skin was slightly, diffusely hyperpigmented.

Lab data included a random glucose of 253 mg/dl, A1C of 7.9%, normal creatinine and electrolytes, aspartate aminotransferase (GOT) of 66 units/l (normal < 44), alanine aminotransferase . . . [Full Text of this Article]


    Questions
 

    Commentary
 

    Clinical Pearls
 

Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2004 by the American Diabetes Association.